Semler Scientific, Inc. (SMLR) Financial Ratios
14 years of historical data (2011–2024) · Healthcare · Medical - Devices
EV/EBITDA
↓
14.04
↓-44% vs avg
5yr avg: 25.14
30Y Low12.7·High44.5
P/FCF
↓
N/A
—
5yr avg: 34.86
30Y Low17.3·High68.1
P/B Ratio
↓
0.70
↓-93% vs avg
5yr avg: 10.65
30Y Low1.9·High62.5
ROE
↓
27.0%
↑-32% vs avg
5yr avg: 39.7%
30Y Low-287%·High175%
Debt/EBITDA
↓
0.00
↓-68% vs avg
5yr avg: 0.01
30Y Low0.0·High0.0
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
SMLR Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Semler Scientific, Inc. trades at 4.0x earnings, 86% below its 5-year average of 28.6x, sitting at the 0th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a discount of 82%.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $311M | $431M | $346M | $264M | $746M | $758M | $385M | $262M | $43M | $7M | $13M |
| Enterprise Value | $302M | $422M | $289M | $241M | $709M | $736M | $378M | $259M | $45M | $9M | $12M |
| P/E Ratio → | 3.96 | 10.53 | 16.84 | 18.44 | 43.23 | 54.02 | 25.53 | 52.12 | — | — | — |
| P/S Ratio | 5.52 | 7.65 | 5.08 | 4.66 | 14.07 | 19.64 | 11.76 | 12.21 | 3.47 | 1.00 | 1.80 |
| P/B Ratio | 0.70 | 1.87 | 4.82 | 4.74 | 16.38 | 25.45 | 29.48 | 62.55 | — | — | — |
| P/FCF | — | — | 20.38 | 17.25 | 48.97 | 52.82 | 34.94 | 68.12 | — | — | — |
| P/OCF | 12.73 | 17.65 | 19.43 | 15.12 | 46.46 | 50.17 | 30.28 | 55.88 | 69.63 | — | — |
P/E links to full P/E history page with 30-year chart
SMLR EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
Semler Scientific, Inc.'s enterprise value stands at 14.0x EBITDA, 44% below its 5-year average of 25.1x. This is roughly in line with the Healthcare sector median of 14.2x.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 7.50 | 4.24 | 4.26 | 13.37 | 19.07 | 11.53 | 12.06 | 3.59 | 1.27 | 1.74 |
| EV / EBITDA | 14.04 | 19.63 | 12.66 | 13.56 | 35.33 | 44.51 | 33.31 | 44.34 | — | — | — |
| EV / EBIT | 14.43 | 20.17 | 12.58 | 14.02 | 36.44 | 44.65 | 35.27 | 48.52 | — | — | — |
| EV / FCF | — | — | 17.02 | 15.76 | 46.54 | 51.28 | 34.24 | 67.26 | — | — | — |
SMLR Profitability
Margins and return-on-capital ratios measuring operating efficiency
Semler Scientific, Inc. earns an operating margin of 37.2%. Operating margins have expanded from 30.3% to 37.2% over the past 3 years, signaling improving operational efficiency. ROE of 27.0% indicates solid capital efficiency. ROIC of 13.3% represents solid returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 91.5% | 91.5% | 89.8% | 92.5% | 88.5% | 91.3% | 88.8% | 87.4% | 79.5% | 74.8% | 59.3% |
| Operating Margin | 37.2% | 37.2% | 32.6% | 30.3% | 36.7% | 41.3% | 32.7% | 24.9% | -6.9% | -29.0% | -120.3% |
| Net Profit Margin | 72.7% | 72.7% | 30.2% | 25.3% | 32.5% | 36.3% | 46.0% | 23.3% | -12.1% | -34.4% | -121.4% |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 27.0% | 27.0% | 32.3% | 28.3% | 45.7% | 65.4% | 174.7% | 621.7% | — | — | -719.2% |
| ROA | 25.7% | 25.7% | 29.2% | 25.3% | 40.4% | 52.9% | 116.0% | 83.9% | -41.3% | -83.0% | -160.7% |
| ROIC | 13.3% | 13.3% | 70.0% | 62.2% | 179.3% | 183.5% | 257.2% | 439.3% | — | — | — |
| ROCE | 13.7% | 13.7% | 34.9% | 33.9% | 51.2% | 73.9% | 123.9% | 323.3% | — | — | -699.5% |
SMLR Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Semler Scientific, Inc. carries a Debt/EBITDA ratio of 0.0x, which is very conservative (100% below the sector average of 3.2x). The company holds a net cash position — cash of $9M exceeds total debt of $70000, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | — | — | — | — | — | — |
| Debt / EBITDA | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.04 | -0.79 | -0.41 | -0.81 | -0.74 | -0.59 | -0.78 | — | — | — |
| Net Debt / EBITDA | -0.41 | -0.41 | -2.50 | -1.28 | -1.84 | -1.34 | -0.68 | -0.56 | — | — | — |
| Debt / FCF | — | — | -3.36 | -1.49 | -2.43 | -1.54 | -0.70 | -0.85 | — | — | — |
| Interest Coverage | — | — | — | — | — | — | — | 17.93 | -1.84 | -5.52 | -97.90 |
Net cash position: cash ($9M) exceeds total debt ($70000)
SMLR Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Semler Scientific, Inc.'s current ratio of 3.59x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has declined from 7.13x to 3.59x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.59 | 3.59 | 10.64 | 7.13 | 9.33 | 5.89 | 2.20 | 1.78 | 0.56 | 0.49 | 0.43 |
| Quick Ratio | 3.54 | 3.54 | 10.56 | 7.06 | 9.22 | 5.82 | 2.20 | 2.57 | 0.82 | 0.76 | 0.74 |
| Cash Ratio | 2.36 | 2.36 | 9.23 | 6.28 | 7.65 | 4.89 | 1.49 | 0.94 | 0.28 | 0.19 | 0.10 |
| Asset Turnover | — | 0.23 | 0.87 | 0.90 | 1.05 | 1.11 | 1.79 | 2.78 | 2.94 | 2.42 | 2.27 |
| Inventory Turnover | 13.29 | 13.29 | 15.69 | 9.07 | 11.13 | 9.87 | — | — | — | — | — |
| Days Sales Outstanding | — | 28.39 | 32.79 | 25.01 | 24.91 | 26.55 | 38.83 | 47.57 | 38.55 | 43.06 | 66.63 |
SMLR Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Semler Scientific, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 25.2% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 25.2% | 9.5% | 5.9% | 5.4% | 2.3% | 1.9% | 3.9% | 1.9% | — | — | — |
| FCF Yield | — | — | 4.9% | 5.8% | 2.0% | 1.9% | 2.9% | 1.5% | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.6% | 1.9% | 0.0% | 0.0% | 1.7% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.6% | 1.9% | 0.0% | 0.0% | 1.7% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $5M | $5M | $5M |
Peer Comparison
Compare SMLR with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 SMLRYou | $311M | 4.0 | 14.0 | — | 91.5% | 37.2% | 27.0% | 13.3% | 0.0 |
 BEAT | $24M | -1.1 | — | — | — | — | -987.3% | — | — |
 AEYE | $76M | -24.3 | 216.7 | 16.2 | 78.3% | -7.9% | -43.2% | -20.1% | 34.1 |
 GXAI | $9M | -2.3 | — | — | 89.4% | -254.3% | -26.6% | -52.2% | — |
 ATEC | $1B | -8.9 | 4030.4 | 466.2 | 69.6% | -10.7% | -630.7% | -12.6% | 1425.2 |
 MDXG | $545M | 11.5 | 5.1 | 7.5 | 82.6% | 15.3% | 21.6% | 42.3% | 0.3 |
 OFIX | $362M | -3.9 | — | — | 67.1% | -8.3% | -19.3% | -8.6% | — |
 PRCT | $1B | -12.2 | — | — | 63.7% | -33.7% | -24.9% | -55.7% | — |
 UNH | $369B | 30.7 | 18.1 | 23.0 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 |
 CVS | $129B | 72.9 | 14.3 | 16.6 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
 HUM | $43B | 36.7 | 22.9 | 115.5 | 14.5% | 1.1% | 7.0% | 4.1% | 5.7 |
| Healthcare Median | — | 22.1 | 14.2 | 18.4 | 63.9% | -4.4% | -33.2% | -11.7% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 14 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
SMLR — Frequently Asked Questions
Quick answers to the most common questions about buying SMLR stock.
What is Semler Scientific, Inc.'s P/E ratio?
Semler Scientific, Inc.'s current P/E ratio is 4.0x. The historical average is 31.5x.
What is Semler Scientific, Inc.'s EV/EBITDA?
Semler Scientific, Inc.'s current EV/EBITDA is 14.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 29.0x.
What is Semler Scientific, Inc.'s ROE?
Semler Scientific, Inc.'s return on equity (ROE) is 27.0%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 12.3%.
Is SMLR stock overvalued?
Based on historical data, Semler Scientific, Inc. is trading at a P/E of 4.0x. Compare with industry peers and growth rates for a complete picture.
What are Semler Scientific, Inc.'s profit margins?
Semler Scientific, Inc. has 91.5% gross margin and 37.2% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
How much debt does Semler Scientific, Inc. have?
Semler Scientific, Inc.'s Debt/EBITDA ratio is 0.0x, indicating low leverage. A ratio below 2x is generally considered financially healthy.